Moneycontrol
HomeNewsIndiaGive money to the poor to revive economy amid COVID-19 crisis: Abhijit Banerjee
Trending Topics

Give money to the poor to revive economy amid COVID-19 crisis: Abhijit Banerjee

Congress leader Rahul Gandhi was in conversation with Nobel laureate Abhijit Banerjee on dealing with the economic fallout as part of his series of deliberations with experts on economy and health.

May 05, 2020 / 13:44 IST
Story continues below Advertisement

File image: Abhijit Banerjee

Spending is the easiest way to revive the economy amid the COVID-19 crisis, Nobel laureate Abhijit Banerjee told Congress leader Rahul Gandhi, adding that a direct transfer to people to spend was a good way to ensure this.

The former Congress president was in conversation with Banerjee on May 5 about the economic fallout as a part of his series of deliberations with experts on economy and health.

Story continues below Advertisement

Banerjee suggested giving money into the hands of the bottom 60 percent population to help revive demand.

To Gandhi's question as to whether some form of the Congress-proposed NYAY scheme or direct cash transfer to people was the need of the hour, Benerjee answered in the affirmative saying it should not be limited just to the poorest.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show